 |
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
Sharma, Manu, Ioannidis, John P. A., Aasly, Jan O., Annesi, Grazia, Brice, Alexis, Bertram, Lars, Bozi, Maria, Barcikowska, Maria, Crosiers, David, Clarke, Carl E., Facheris, Maurizio F., Farrer, Matthew, Garraux, Gaetan, Gispert, Suzana, Auburger, Georg, Vilarino-Guell, Carles, Hadjigeorgiou, Georgios M., Hicks, Andrew A., Hattori, Nobutaka, Jeon, Beom S., Jamrozik, Zygmunt, Krygowska-Wajs, Anna, Lesage, Suzanne, Lill, Christina M., Lin, Juei-Jueng, Lynch, Timothy, Lichtner, Peter, Lang, Anthony E., Libioulle, Cecile, Murata, Miho, Mok, Vincent, Jasinska-Myga, Barbara, Mellick, George D., Morrison, Karen E., Meitnger, Thomas, Zimprich, Alexander, Opala, Grzegorz, Pramstaller, Peter P., Pichler, Irene, Park, Sung Sup, Quattrone, Aldo, Rogaeva, Ekaterina, Ross, Owen A., Stefanis, Leonidas, Stockton, Joanne D., Satake, Wataru, Silburn, Peter A., Strom, Tim M., Theuns, Jessie, Tan, Eng-King, Toda, Tatsushi, Tomiyama, Hiroyuki, Uitti, Ryan J., Van Broeckhoven, Christine, Wirdefeldt, Karin, Wszolek, Zbigniew, Xiromerisiou, Georgia, Yomono, Harumi S., Yueh, Kuo-Chu, Zhao, Yi, Gasser, Thomas, Maraganore, Demetrius, Krueger, Rejko and GEOPD consortium (2012) A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. Journal of Medical Genetics, 49 11: 721-726.
|
|
|
|
Cited 
